No clear evidence that cannabis-based medicines relieve chronic nerve pain

There is no clear evidence that cannabis-based medicines provide pain relief for chronic neuropathic pain, an updated Cochrane review finds

2026-01-19

(Press-News.org) There is no clear evidence that cannabis-based medicines provide pain relief for chronic neuropathic pain, an updated Cochrane review finds.

Chronic neuropathic pain is caused by nerve damage. Existing medications help only a minority of patients, driving interest in alternatives, such as cannabis-based medicines. These can include herbal cannabis or isolated ingredients of the cannabis plant such as tetrahydrocannabinol (THC) by inhalation, mouth sprays, tablets, creams, and patches placed on the skin.

Researchers reviewed 21 clinical trials involving more than 2,100 adults, comparing cannabis-based medicines with placebo over periods of two to 26 weeks.

Cannabis-based medicines were grouped into three types: products which contain mostly THC, the psychoactive component of cannabis; products which contain mostly cannabidiol (CBD), a non-intoxicating compound; and balanced THC/CBD products, which contain similar amounts of both.

The review found no high-quality evidence that cannabis-based medicines reduce neuropathic pain more than placebo across the three types of medicines. While some small improvements were reported by patients using products with both THC and CBD, these changes were not large enough to be considered clinically meaningful.

Reporting of adverse events was not consistent across the included trials, so certainty around side-effects was low to very low across all types of cannabis-based medicines. Products containing THC were associated with increases in symptoms such as dizziness and drowsiness, with a potential increase in the number of people withdrawing from trials due to side effects.

“We need larger, well-designed studies with a treatment duration of at least 12 weeks that include people with comorbid physical illnesses and mental health conditions to fully understand the benefits and harms of cannabis-based medicines,” said Winfried Häuser, clinician and lead author, from Technische Universität München and Medical Center Pain Medicine and Mental Health Saarbrücken. “At present, the quality of most of the trials is too poor to draw firm conclusions.”

The authors conclude that the evidence remains weak and uncertain, underscoring the need for higher-quality research before cannabis-based medicines can be recommended for chronic neuropathic pain.

END

ELSE PRESS RELEASES FROM THIS DATE:

Pioneering second-order nonlinear vibrational nanoscopy for interfacial molecular systems beyond the diffraction limit

2026-01-19

Sum-frequency generation (SFG) is a powerful vibrational spectroscopy that can selectively probe molecular structures at surfaces and interfaces, but its spatial resolution has been limited to the micrometer scale by the diffraction limit of light. Here, we overcame this limitation by utilizing a highly confined near field within a plasmonic nanogap and successfully extended the SFG spectroscopy into nanoscopic regime with ~10-nm spatial resolution. We also established a comprehensive theoretical framework that accurately describes the microscopic mechanisms of this near-field SFG process. These experimental and theoretical achievements ...

Bottleneck in hydrogen distribution jeopardises billions in clean energy

2026-01-19

A recent study from Edinburgh Business School at Heriot-Watt University found that while hydrogen production, storage and fuel cell technologies are advancing rapidly, the hydrogen distribution infrastructure is developing at half the speed, creating a critical bottleneck that could put billions in clean energy at risk. The findings, published in the journal Sustainable Futures, are an important milestone in recognising that, while other hydrogen technologies improve and costs fall, distribution expenses could take up a large share of hydrogen system budgets, significantly limiting overall efficiency and growth of ...

Lung cancer death rates among women in Europe are finally levelling off

2026-01-19

After increasing for more than 25 years, lung cancer death rates are finally levelling off among women in European Union (EU) countries apart from Spain, according to predictions of mortality rates from the disease for 2026. In the UK, death rates from lung cancer have been falling among women for several years, although from a higher peak than those seen in the EU, but they have continued to rise among EU women during this time. Now, in a new study published in the leading cancer journal Annals of ...

Scientists trace microplastics in fertilizer from fields to the beach

2026-01-17

Tokyo, Japan – Researchers from Tokyo Metropolitan University have studied how polymer-coated fertilizer (PCF) applied to fields ends up on beaches and in the sea. They studied PCF deposits on beaches around Japan, finding that only 0.2% of used PCFs are washed into rivers and returned to the coastline. When there are canals connecting fields to the sea, this rises to 28%. Their findings highlight a potentially significant “sink” in the global circulation of plastics. Plastic marine pollution poses a serious threat to wildlife, ecosystems, and human health. It is estimated that around 90% of the plastic that has flowed out to sea has disappeared from ...

The Lancet Obstetrics, Gynecology, & Women’s Health: Taking paracetamol during pregnancy does not increase risk of autism, ADHD or intellectual disabilities, confirms new gold-standard evidence review

2026-01-17

There is no evidence that paracetamol use during pregnancy increases the risk of autism, attention-deficit/hyperactivity disorder (ADHD), or intellectual disability among children, finds most rigorous synthesis of the current evidence to date published in The Lancet Obstetrics, Gynaecology, & Women’s Health journal. In September 2025 the U.S. administration suggested that taking paracetamol during pregnancy might increase the risk of autism among children. Earlier meta-analyses suggested small associations between ...

Taking paracetamol during pregnancy does not increase risk of autism, ADHD or intellectual disabilities

2026-01-17

Under embargo until Friday 16th January 2026, 23:30hrs UK time City St George’s, University of London press release Peer-reviewed / Systematic review + meta-analysis / People Taking paracetamol during pregnancy does not increase the risk of autism, attention-deficit hyperactivity disorder (ADHD), or intellectual disability among children. That is according to the most rigorous analysis of the evidence to date published today in The Lancet Obstetrics, Gynaecology & Women’s Health, and led ...

Harm reduction vending machines in New York State expand access to overdose treatment and drug test strips, UB studies confirm

2026-01-16

BUFFALO, N.Y. – Two studies led by an opioid treatment program run by the University at Buffalo and UBMD Emergency Medicine have found that harm reduction vending machines installed across New York State are well utilized and provide critical, lifesaving services to high-risk individuals who might not otherwise have access. The studies, published late last year, evaluate the performance of the 15 harm reduction vending machines installed throughout New York State by the MATTERS Network, based at UBMD Emergency Medicine and UB. MATTERS (Medication for Addiction Treatment and Electronic Referrals) now operates 30 harm reduction vending machines in New York State ...

University of Phoenix releases white paper on Credit for Prior Learning as a catalyst for internal mobility and retention

2026-01-16

University of Phoenix announced the publication of a new white paper, “Untapped Potential: How Credit for Prior Learning Can Redefine Employer Outlook on Professional Development,” by Devin Andrews, MBA, M.Ed., Vice President of Admissions and Evaluation. The report draws on a national University of Phoenix employee engagement and retention survey of 610 human resources (HR) managers and 1,195 employees conducted by The Harris Poll that examined how credit for prior learning (CPL) impacts internal mobility, employee retention and skills development. The analysis finds 98% of HR managers are aware of CPL—and ...

Canada losing track of salmon health as climate and industrial threats mount

2026-01-16

Canada is failing in a decades-old pledge to monitor the health of Pacific salmon, according to new research from Simon Fraser University. At a time when government policy is geared towards accelerating industrial development across sensitive B.C. watersheds, an SFU study published today in the Canadian Journal of Fisheries and Aquatic Sciences reports that monitoring of salmon spawning populations has dropped 32 per cent since Canada adopted its Wild Salmon Policy 20 years ago. The decline in publicly-available data means that scientists are ...

Molecular sieve-confined Pt-FeOx catalysts achieve highly efficient reversible hydrogen cycle of methylcyclohexane-toluene

2026-01-16

Professor Qiming Sun of Soochow University and Researcher Manyi Yang of Nanjing University successfully achieved confined loading of highly dispersed Pt-FeOx nanoparticles within nanosheet molecular sieves. This catalyst exhibited excellent catalytic performance in the dehydrogenation of methylcyclohexane and the hydrogenation of toluene, realizing hydrogen energy storage and release mediated by the "methylcyclohexane-toluene" reaction. The study shows that the Pt-FeOx catalyst possesses excellent ...

LAST 30 PRESS RELEASES:

Cancer and inflammation: immunologic interplay, translational advances, and clinical strategies

Bioactive polyphenolic compounds and in vitro anti-degenerative property-based pharmacological propensities of some promising germplasms of Amaranthus hypochondriacus L.